The Infectious Diseases Clinical Research Consortium has begun enrolling up to 1,000 pregnant and postpartum individuals who have or will receive COVID-19 vaccine in a study to assess vaccine safety, immune response and transfer of antibodies to their infants, the National Institutes of Health announced yesterday. The study will enroll individuals up to two months postpartum, and follow participants and their infants through the first year after delivery.

“Tens of thousands of pregnant and breastfeeding people in the United States have chosen to receive the COVID-19 vaccines available under emergency use authorization,” said Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases “However, we lack robust, prospective clinical data on vaccination in these populations. The results of this study will fill gaps in our knowledge and help inform policy recommendations and personal decision-making on COVID-19 vaccination during pregnancy and in the postpartum period.”
 

Headline
A new AHA toolkit offers practical strategies to strengthen rural maternal care, drawing on insights from 160 leaders representing 92 hospitals and health…
Headline
The Food and Drug Administration Oct. 29 issued a proposed rule to update infant formula nutrient requirements, the first such update since 1998. The proposal…
Headline
Extending Medicaid coverage by 12 months following childbirth increased use of postpartum care among mothers with pregnancy complications such as diabetes and…
Headline
The Centers for Disease Control and Prevention issued a reminder Oct. 14 that the declaration supporting the emergency use of COVID-19 in vitro diagnostics…
Headline
A new blog, part of the Keeping Care Close to Home initiative, discusses how connected care networks are essential to sustaining rural maternal care. The blog…
Blog
When the American Hospital Association launched the Keeping Care Close to Home: Innovations in Rural Maternal Health project in 2025, we set out to understand…